# Lakeland Financial Corp: financial statements, quarterly

LKFN · Nasdaq · CIK 721994 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/lkfn.md) · [Financials](/companies/lkfn/financials.md) · [Filings](/companies/lkfn/filings.md) · [Insiders](/companies/lkfn/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/lkfn/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $m | [40.2](/filings/0000721994-24-000013.md) | [42.3](/filings/0000721994-24-000013.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [4.5](/filings/0000721994-25-000087.md) | [6.4](/filings/0000721994-25-000087.md) | [4.4](/filings/0000721994-26-000018.md) | [4.4](/filings/0000721994-26-000018.md) | [4.4](/filings/0000721994-26-000018.md) | [5.0](/filings/0000721994-26-000018.md) | [4.2](/filings/0000721994-26-000053.md) | [6.0](/filings/0000721994-26-000067.md) | [5.7](/filings/0000721994-26-000018.md) | [6.4](/filings/0000721994-26-000018.md) | [6.1](/filings/0000721994-26-000053.md) | [6.3](/filings/0000721994-26-000067.md) |
| Net income | $m | [25.3](/filings/0000721994-25-000087.md) | [29.6](/filings/0000721994-25-000087.md) | [23.4](/filings/0000721994-26-000018.md) | [22.5](/filings/0000721994-26-000018.md) | [23.3](/filings/0000721994-26-000018.md) | [24.2](/filings/0000721994-26-000018.md) | [20.1](/filings/0000721994-26-000053.md) | [27.0](/filings/0000721994-26-000067.md) | [26.4](/filings/0000721994-26-000018.md) | [29.9](/filings/0000721994-26-000018.md) | [26.5](/filings/0000721994-26-000053.md) | [28.4](/filings/0000721994-26-000067.md) |
| Diluted EPS | $ per share | [0.98](/filings/0000721994-25-000087.md) | [1.16](/filings/0000721994-25-000087.md) | [0.91](/filings/0000721994-26-000018.md) | [0.87](/filings/0000721994-26-000018.md) | [0.91](/filings/0000721994-26-000018.md) | [0.94](/filings/0000721994-26-000018.md) | [0.78](/filings/0000721994-26-000053.md) | [1.04](/filings/0000721994-26-000067.md) | [1.03](/filings/0000721994-26-000018.md) | [1.16](/filings/0000721994-26-000018.md) | [1.04](/filings/0000721994-26-000053.md) | [1.13](/filings/0000721994-26-000067.md) |
| Basic EPS | $ per share | [0.99](/filings/0000721994-25-000087.md) | [1.16](/filings/0000721994-25-000087.md) | [0.91](/filings/0000721994-26-000018.md) | [0.88](/filings/0000721994-26-000018.md) | [0.91](/filings/0000721994-26-000018.md) | [0.94](/filings/0000721994-26-000018.md) | [0.78](/filings/0000721994-26-000053.md) | [1.05](/filings/0000721994-26-000067.md) | [1.03](/filings/0000721994-26-000018.md) | [1.16](/filings/0000721994-26-000018.md) | [1.04](/filings/0000721994-26-000053.md) | [1.14](/filings/0000721994-26-000067.md) |

- Revenue: not reported
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [146](/filings/0000721994-23-000071.md) | [152](/filings/0000721994-25-000087.md) | [148](/filings/0000721994-24-000035.md) | [121](/filings/0000721994-24-000120.md) | [160](/filings/0000721994-24-000140.md) | [168](/filings/0000721994-26-000018.md) | [235](/filings/0000721994-25-000128.md) | [310](/filings/0000721994-25-000213.md) | [193](/filings/0000721994-25-000228.md) | [141](/filings/0000721994-26-000067.md) | [151](/filings/0000721994-26-000053.md) | [194](/filings/0000721994-26-000067.md) |
| Total assets | $m | [6,427](/filings/0000721994-23-000071.md) | [6,524](/filings/0000721994-25-000087.md) | [6,567](/filings/0000721994-24-000035.md) | [6,569](/filings/0000721994-24-000120.md) | [6,645](/filings/0000721994-24-000140.md) | [6,678](/filings/0000721994-26-000018.md) | [6,851](/filings/0000721994-25-000128.md) | [6,964](/filings/0000721994-25-000213.md) | [6,895](/filings/0000721994-25-000228.md) | [6,990](/filings/0000721994-26-000067.md) | [7,084](/filings/0000721994-26-000053.md) | [7,243](/filings/0000721994-26-000067.md) |
| Total liabilities | $m | [5,870](/filings/0000721994-23-000071.md) | [5,874](/filings/0000721994-25-000087.md) | [5,920](/filings/0000721994-24-000035.md) | [5,914](/filings/0000721994-24-000120.md) | [5,946](/filings/0000721994-24-000140.md) | [5,994](/filings/0000721994-26-000018.md) | [6,157](/filings/0000721994-25-000128.md) | [6,254](/filings/0000721994-25-000213.md) | [6,148](/filings/0000721994-25-000228.md) | [6,228](/filings/0000721994-26-000067.md) | [6,335](/filings/0000721994-26-000053.md) | [6,470](/filings/0000721994-26-000067.md) |
| Long-term debt | $m | [90.0](/filings/0000721994-23-000071.md) | [50.0](/filings/0000721994-24-000140.md) | not reported | [55.0](/filings/0000721994-24-000120.md) | [30.0](/filings/0000721994-24-000140.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [557](/filings/0000721994-23-000071.md) | [650](/filings/0000721994-25-000087.md) | [647](/filings/0000721994-24-000035.md) | [655](/filings/0000721994-24-000120.md) | [699](/filings/0000721994-24-000140.md) | [684](/filings/0000721994-26-000018.md) | [694](/filings/0000721994-25-000128.md) | [710](/filings/0000721994-25-000213.md) | [747](/filings/0000721994-25-000228.md) | [762](/filings/0000721994-26-000067.md) | [749](/filings/0000721994-26-000053.md) | [773](/filings/0000721994-26-000067.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [50.6 d](/filings/0000721994-24-000140.md) | [26.5 d](/filings/0000721994-26-000018.md) | [24.8](/filings/0000721994-25-000128.md) | [21.0 d](/filings/0000721994-25-000213.md) | [18.0 d](/filings/0000721994-25-000228.md) | [38.7 d](/filings/0000721994-26-000018.md) | [28.9](/filings/0000721994-26-000053.md) | [16.2 d](/filings/0000721994-26-000067.md) | [36.1 d](/filings/0000721994-25-000228.md) | [33.7 d](/filings/0000721994-26-000018.md) | [34.7](/filings/0000721994-26-000053.md) | [24.4 d](/filings/0000721994-26-000067.md) |
| Capital expenditure | $m | [1.2 d](/filings/0000721994-24-000140.md) | [1.0 d](/filings/0000721994-26-000018.md) | [1.5](/filings/0000721994-25-000128.md) | [2.4 d](/filings/0000721994-25-000213.md) | [2.7 d](/filings/0000721994-25-000228.md) | [2.0 d](/filings/0000721994-26-000018.md) | [1.8](/filings/0000721994-26-000053.md) | [2.1 d](/filings/0000721994-26-000067.md) | [5.0 d](/filings/0000721994-25-000228.md) | [2.2 d](/filings/0000721994-26-000018.md) | [4.7](/filings/0000721994-26-000053.md) | [5.2 d](/filings/0000721994-26-000067.md) |
| Dividends paid | $m | [11.8 d](/filings/0000721994-24-000140.md) | [11.8 d](/filings/0000721994-26-000018.md) | [12.3](/filings/0000721994-25-000128.md) | [12.3 d](/filings/0000721994-25-000213.md) | [12.3 d](/filings/0000721994-25-000228.md) | [12.3 d](/filings/0000721994-26-000018.md) | [12.8](/filings/0000721994-26-000053.md) | [12.9 d](/filings/0000721994-26-000067.md) | [12.9 d](/filings/0000721994-25-000228.md) | [12.9 d](/filings/0000721994-26-000018.md) | [13.2](/filings/0000721994-26-000053.md) | [13.0 d](/filings/0000721994-26-000067.md) |
| Share repurchases | $m | [0.2 d](/filings/0000721994-24-000140.md) | [0.1 d](/filings/0000721994-26-000018.md) | [0.2](/filings/0000721994-25-000128.md) | [0.1 d](/filings/0000721994-25-000213.md) | [0.2 d](/filings/0000721994-25-000228.md) | [0.1 d](/filings/0000721994-26-000018.md) | [0.2](/filings/0000721994-26-000053.md) | [1.8 d](/filings/0000721994-26-000067.md) | [0.2 d](/filings/0000721994-25-000228.md) | [18.2 d](/filings/0000721994-26-000018.md) | [19.6](/filings/0000721994-26-000053.md) | [4.3 d](/filings/0000721994-26-000067.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [25.7](/filings/0000721994-23-000071.md) | [25.7](/filings/0000721994-24-000035.md) | [25.7](/filings/0000721994-24-000120.md) | [25.7](/filings/0000721994-24-000140.md) | [25.7](/filings/0000721994-25-000128.md) | [25.7](/filings/0000721994-25-000213.md) | [25.8](/filings/0000721994-25-000228.md) | [25.8](/filings/0000721994-26-000053.md) | [25.8](/filings/0000721994-26-000067.md) | [25.8](/filings/0000721994-25-000228.md) | [25.5](/filings/0000721994-26-000053.md) | [25.2](/filings/0000721994-26-000067.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 24,857,840 at 2026-07-29, from the cover of the [10-Q filed 2026-08-05](/filings/0000721994-26-000067.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:23 ET. No prices; not investment advice.